Treatment with UPA led to improvements across axial and peripheral PsA domains over 12 months, while maintaining high rates of treatment persistence.
For patients with rheumatoid arthritis (RA), methotrexate significantly reduces systolic blood pressure (SBP), according to a study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback